Browsing by Author Kudo, M. (Masatoshi)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleTypeAuthor(s)
2021CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosisArticuloKudo, M. (Masatoshi); Matilla, A. (Ana); Santoro, A. (Armando); Melero, I. (Ignacio); Cubillo-Gracián, A. (Antonio); Acosta-Rivera, M. (Mirelis); Choo, S.P. (Su-Pin); El-Khoueiry, A. (Anthony); Kuromatsu, R. (Ryoko); El-Rayes, B.F. (Bassel F.); Numata, K. (Kazushi); Itoh, Y. (Yoshito); Di-Costanzo, F. (Francesco); Crysler, O. (Oxana); Reig, M. (Maria); Shen, Y. (Yun); Neely, J. (Jaclyn); Tschaika, M. (Marina); Wisniewski, T. (Tami); Sangro, B. (Bruno)
2020Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical TrialArticuloYau, T. (Thomas); Kang, Y.K. (Yoon-Koo); Kim, T.Y. (Tae-You); El-Khoueiry, A. (Anthony); Santoro, A. (Armando); Sangro, B. (Bruno); Melero, I. (Ignacio); Kudo, M. (Masatoshi); Hou, M.M. (Ming-Mo); Matilla, A. (Ana); Tovoli, F. (Francesco); Knox, J.J. (Jennifer J.); He, A.R. (Aiwu Ruth); El-Rayes, B.F. (Bassel F.); Acosta-Rivera, M. (Mirelis); Lim, H.Y. (Ho-Yeong); Neely, J. (Jaclyn); Shen, Y. (Yun); Wisniewski, T. (Tami); Anderson, J. (Jeffrey); Hsu, C. (Chiun)
2023Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040ArticuloEl-Khoueiry, A. (Anthony); Trojan, J. (Jörg); Meyer, T. (Tim); Yau, T. (Thomas); Melero, I. (Ignacio); Kudo, M. (Masatoshi); Hsu, C. (Chiun); Kim, T.Y. (Tae-You); Choo, S.P. (Su-Pin); Kang, Y.K. (Yoon-Koo); Yeo, W. (W.); Chopra, A. (A.); Soleymani, S. (S.); Yao, J. (J.); Neely, J. (Jaclyn); Tschaika, M. (Marina); Welling, T.H. (T. H.); Sangro, B. (Bruno)
2022Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialArticuloYau, T. (Thomas); Park, J.W. (Joong-Won); Finn, R.S. (Richard S.); Cheng, A.L. (Ann-Lii); Mathurin, P. (Philippe); Edeline, J. (Julien); Kudo, M. (Masatoshi); Harding, J.J. (James J.); Merle, P. (Philippe); Rosmorduc, O. (Olivier); Wyrwicz, L. (Lucjan); Schott, E. (Eckart); Choo, S.P. (Su-Pin); Kate-Kelley, R. (Robin); Sieghart, W. (Wolfgang); Assenat, E. (Eric); Zaucha, R. (Renata); Furuse, J. (Junji); Abou-Alfa, G.K. (Ghassan K.); El-Khoueiry, A. (Anthony); Melero, I. (Ignacio); Begic, D. (Damir); Chen, G. (Gong); Neely, J. (Jaclyn); Wisniewski, T. (Tami); Tschaika, M. (Marina); Sangro, B. (Bruno)
2020Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma: A response-based approachArticuloHan, G. (Guohong); Berhane, S. (Sarah); Toyoda, H. (Hidenori); Bettinger, D. (Dominik); Elshaarawy, O. (Omar); Chan, A.W.H. (Anthony W. H.); Kirstein, M. (Martha); Mosconi, C. (Cristina); Hucke, F. (Florian); Palmer, D. (Daniel); Pinato, D.J. (David J.); Sharma, R. (Rohini); Ottaviani, D. (Diego); Jang, J.W. (Jeong W.); Labeur, T.A. (Tim A.); Delden, O.M. (Otto M.) van; Pirisi, M. (Mario); Stern, N. (Nick); Sangro, B. (Bruno); Meyer, T. (Tim); Fateen, W. (Waleed); García-Fiñana, M. (Marta); Gomaa, A. (Asmaa); Waked, I. (Imam); Rewisha, E. (Eman); Aithal, G.P. (Guru P.); Travis, S. (Simon); Kudo, M. (Masatoshi); Cucchetti, A. (Alessandro); Peck-Radosavljevic, M. (Markus); Takkenberg, R.B. (R. B.); Chan, S.L. (Stephen L.); Vogel, A. (Arndt); Johnson, P.J. (Philip J.)